Medical technology company C.R. Bard Inc. announced Wednesday that its Board of Directors had approved the repurchase of up to $500 million in common stock.
This amount increases the approximately $30 million remaining from a previous repurchase authorization in January.
C.R. Bard has its headquarters in Murray Hill.
ALSO ON NJBIZ:
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy